Features, pricing, ratings, and pros & cons — compared head-to-head.
Clavister IdAuth is a commercial access management tool by Clavister. Exostar Secure Access Manager (SAM) is a commercial access management tool by Exostar. Compare features, ratings, integrations, and community reviews side by side to find the best access management fit for your security stack.
Based on our analysis of NIST CSF 2.0 coverage, core features, integrations, company size fit, here is our conclusion:
Mid-market and enterprise teams in regulated industries will benefit most from Clavister IdAuth's native support for BankID and Freja eID, which eliminates custom integrations for European compliance workflows. The platform covers NIST PR.AA Identity Management through conditional access policies tied to device state and risk signals, giving you granular control without the overhead of separate policy engines. Skip this if you need deep integration with US-centric identity ecosystems or plan to run entirely cloud-native; the hybrid deployment model works best for organizations already committed to on-premises infrastructure.
Exostar Secure Access Manager (SAM)
Enterprise security teams managing clinical trial ecosystems should use Exostar Secure Access Manager for its purpose-built SSO across 122+ trial applications, eliminating the friction of federated identity management across sponsor and site networks. The platform's automated provisioning workflows combined with real-time audit trails and training compliance tracking directly address FDA and ICH regulatory requirements that generic IAM platforms treat as afterthoughts. Not the right fit for organizations needing broad identity governance across non-clinical workloads; this tool's strength is precisely its narrow specialization in trial access workflows.
IdP platform offering MFA, SSO, and conditional access for orgs.
IAM platform for clinical trial access mgmt with SSO across 122+ apps.
Access NIST CSF 2.0 data from thousands of security products via MCP to assess your stack coverage.
Access via MCPNo reviews yet
No reviews yet
Explore more tools in this category or create a security stack with your selections.
Common questions about comparing Clavister IdAuth vs Exostar Secure Access Manager (SAM) for your access management needs.
Clavister IdAuth: IdP platform offering MFA, SSO, and conditional access for orgs. built by Clavister. Core capabilities include Multi-Factor Authentication (MFA) via Clavister OneID mobile app with biometric support, Single Sign-On (SSO) with centralised authentication across services, Conditional access based on device state, network, time of day, and risk signals..
Exostar Secure Access Manager (SAM): IAM platform for clinical trial access mgmt with SSO across 122+ apps. built by Exostar. Core capabilities include Single Sign-On (SSO) across 122+ clinical trial applications, Delegated administration for sponsor and site teams, Automated rules-based access provisioning workflows..
Both serve the Access Management market but differ in approach, feature depth, and target audience.
Clavister IdAuth differentiates with Multi-Factor Authentication (MFA) via Clavister OneID mobile app with biometric support, Single Sign-On (SSO) with centralised authentication across services, Conditional access based on device state, network, time of day, and risk signals. Exostar Secure Access Manager (SAM) differentiates with Single Sign-On (SSO) across 122+ clinical trial applications, Delegated administration for sponsor and site teams, Automated rules-based access provisioning workflows.
Clavister IdAuth is developed by Clavister. Exostar Secure Access Manager (SAM) is developed by Exostar. Vendor maturity, funding stage, and team size can be important factors when evaluating long-term viability and support quality.
Clavister IdAuth and Exostar Secure Access Manager (SAM) serve similar Access Management use cases: both are Access Management tools, both cover SSO, Single Sign On. Review the feature comparison above to determine which fits your requirements.
Get strategic cybersecurity insights in your inbox